Shares more than doubled in value after Phase 3 results suggested Alumis’ pill may compare favorably with other emerging oral ...
In this report, Datamonitor assesses the main events which shaped the psoriasis market in the past five years, and speculates on major events set to impact over the next ten years. Datamonitor focuses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback